Healthcare Services

Ataxia Market Growth Expected to Reach $61.91 Billion by 2030 with 8.9% CAGR

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Ataxia Market During The Forecast Period 2026–2030?

The ataxia market has demonstrated robust growth over recent years. It is anticipated to expand from $40.45 billion in 2025 to $43.95 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be linked to several factors, including enhanced recognition of neurological disorders, the increasing availability of diagnostic imaging, intensified research into rare neurological diseases, a rising clinical understanding of ataxia subtypes, and the provision of various supportive care options.

The ataxia market is anticipated to show significant expansion over the coming years. It is projected to reach $61.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This growth during the forecast period is attributable to factors such as increased investments in gene-based therapies, the rising embrace of personalized neurology treatments, the widening scope of digital monitoring for neurological conditions, a heightened focus on rare disease drug development, and increased collaborative efforts in neurological research. Prominent trends within this period are expected to include a greater emphasis on genetic testing and counseling, an increase in the adoption of symptomatic treatment approaches, the expanding application of advanced neurodiagnostic tools, the broadening of long-term disease management strategies, and an intensified focus on early diagnosis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12218&type=smp

Which Economic Or Industry Drivers Are Impacting The Ataxia Market?

Future expansion of the ataxia market is anticipated, fueled by increasing alcohol intake. Drinking ethanol-containing beverages, typically by mouth, constitutes alcohol consumption. Chronic alcohol abuse leads to cerebellar degeneration, a common form of acquired toxic ataxia. Individuals suffering from alcoholism often exhibit gait ataxia and postural tremors in their lower limbs. For example, GOV.UK, a UK government body, reported in August 2024 that preliminary alcohol duty revenue from wine and other fermented items for the May to July 2024 period reached $1,523 million (£1,154 million). This represents a $42 million (£32 million) (2.9%) rise compared to the corresponding period of the previous year. Consequently, the increased consumption of alcohol is a key factor propelling the expansion of the ataxia market.

What Market Segments Are Evaluated Within The Ataxia Market?

The ataxia market covered in this report is segmented –

1) By Disease Type: Friedreich’s Ataxia, Ataxia-telangiectasia, Episodic Ataxia, Other Disease Types

2) By Product: Treatment, Diagnosis

3) By Dosage Form: Solid, Liquids, Other Dosage Forms

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End User: Hospital, Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Friedreich’s Ataxia: Genetic Counseling And Testing, Symptomatic Treatments

2) By Ataxia-telangiectasia: Immunotherapy, Supportive Care

3) By Episodic Ataxia: Medications For Episodes, Long-term Management Strategies

4) By Other Disease Types: Spinocerebellar Ataxias (SCAs), Ataxia Due To Vitamin Deficiencies Or Toxins

What Trends Are Affecting The Expansion Of The Ataxia Market?

Leading companies in the ataxia market are concentrating on developing innovative solutions, such as pioneering oral drug therapies, to address the increasing demand for effective treatment options that can decelerate disease progression and enhance functional outcomes in rare neurodegenerative conditions. These oral therapies offer a convenient, non-invasive alternative to traditional supportive care approaches, which primarily manage symptoms without modifying underlying disease pathways. For instance, in February 2023, Reata Pharmaceuticals, a US-based biotechnology company, announced the FDA’s (the U.S. Food and Drug Administration’s) approval of SKYCLARYS (omavaloxolone). It is the first and only drug indicated for patients with Friedreich’s ataxia in adults and adolescents aged 16. At Week 48, treatment with the oral, once-daily medication SKYCLARYS led to statistically significant lower mFARS (modified Friedreich’s Ataxia Rating Scale) scores (reduced impairment) compared to placebo. The diagnosis of Friedreich’s ataxia, an extremely rare inherited neurological condition, usually occurs around adolescence.

Who Are The Top Market Participants Influencing The Ataxia Market?

Major companies operating in the ataxia market are Pfizer Inc., Johnson & Johnson Services Inc., Eisai Co. Ltd., Genentech Inc., CRISPR Therapeutics AG, Eli Lilly & Company, GlaxoSmithKline Plc, Larimar Therapeutics Inc., Capsida Biotherapeutics Inc., Intellia Therapeutics Inc., Bluebird bio Inc., Editas Medicine Inc., Healx, Acorda Therapeutics Inc., H. Lundbeck A/S, Reata Pharmaceuticals Inc., PTC Therapeutics, Ionis Pharmaceuticals Inc., IntraBio, Biogen Inc., Novartis AG, Sanofi, Roche Holding Ltd., Teva Pharmaceuticals, Zydus Lifesciences Ltd

Read the full ataxia market report here:

https://www.thebusinessresearchcompany.com/report/ataxia-global-market-report

What Are The Top-Performing Regions Within The Ataxia Market?

North America was the largest region in the ataxia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the ataxia market report during the forecast period. The regions covered in the ataxia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ataxia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12218&type=smp

Browse Through More Reports Similar to the Global Ataxia Market 2026, By The Business Research Company

Molecular Breeding Global Market Report

https://www.thebusinessresearchcompany.com/report/molecular-breeding-global-market-report

Genetic Testing Services Global Market Report

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795